Thymosin alpha-1 activated immune cells through IKK (NF-κB pathway) and p38 MAPK signaling cascades, identifying the specific intracellular pathways mediating its immunostimulatory effects.
Key findingThymosin alpha-1 activated IKK and p38 MAPK signaling pathways in immune cells, identifying these kinase cascades as the specific intracellular mediat
What the researchers found
Thymosin alpha-1 activated IKK and p38 MAPK signaling pathways in immune cells, identifying these kinase cascades as the specific intracellular mediators of its immunostimulatory effects — molecular targets for optimizing thymosin alpha-1 therapy.
Why it matters
Relevant for thymosin-alpha-1, immune-function, receptor-signaling.
How the study worked
in-vitro study on thymosin-alpha-1, immune-function.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2007.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Signaling pathways leading to the activation of IKK and MAPK by thymosin alpha1.
Annals of the New York Academy of Sciences, 1112, 339-50
Citation
Peng, Xiao; Zhang, Ping; Wang, Xin; Chan, Justin; Zhu, Mingwei; Jiang, Meisheng; Tuthill, Cynthia; Wan, Yinsheng; Dragoi, Ana Maria; Chu, Wen-Ming. (2007). Signaling pathways leading to the activation of IKK and MAPK by thymosin alpha1.. Annals of the New York Academy of Sciences, 1112, 339-50.